Principios del tratamiento quirúrgico de los sarcomas de tejidos blandos

Autor: Schubert, T., Mazzeo, F., de ville de Goyet, M., Geets, X., Docquier, P.-L., Galant, C., Kirchgesner, T.

Publikováno v: In EMC - Técnicas quirúrgicas - Ortopedia y traumatología December 2022 14(4):1-18

MRI-based Zero Echo Time and Black Bone Pseudo-CT Compared with Whole-Body CT to Detect Osteolytic Lesions in Multiple Myeloma.

Autor: Lecouvet FE; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Zan D; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Lepot D; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Chabot C; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Vekemans MC; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Duchêne G; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Chiabai O; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Triqueneaux P; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Kirchgesner T; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Taihi L; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Poujol J; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Gheysens O; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.)., Michoux N; From the Departments of Medical Imaging (F.E.L., D.Z., C.C., P.T., T.K., L.T., N.M.), Hematology (M.C.V.), and Nuclear Medicine (O.G.), Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels, Avenue Hippocrate 10, B-1200 Brussels, Belgium; Department of Medical Imaging, Hôpitaux Universitaires de Genève, Geneva, Switzerland (D.L.); GE HealthCare, Diegem, Belgium (G.D.); Department of Medical Imaging, CHU Saint Pierre, Brussels, Belgium (O.C.); and GE HealthCare, Buc, France (J.P.).

Publikováno v: Radiology [Radiology] 2024 Oct; Vol. 313 (1), pp. e231817.

Present and future of whole-body MRI in metastatic disease and myeloma: how and why you will do it.

Autor: Lecouvet FE; Department of Medical Imaging, Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Avenue Hippocrate, 10, B-1200, Brussels, Belgium. frederic.lecouvet@saintluc.uclouvain.be., Chabot C; Department of Medical Imaging, Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Avenue Hippocrate, 10, B-1200, Brussels, Belgium., Taihi L; Department of Medical Imaging, Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Avenue Hippocrate, 10, B-1200, Brussels, Belgium., Kirchgesner T; Department of Medical Imaging, Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Avenue Hippocrate, 10, B-1200, Brussels, Belgium., Triqueneaux P; Department of Medical Imaging, Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Avenue Hippocrate, 10, B-1200, Brussels, Belgium., Malghem J; Department of Medical Imaging, Institut de Recherche Expérimentale et Clinique (IREC), Institut du Cancer Roi Albert II, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Avenue Hippocrate, 10, B-1200, Brussels, Belgium.

Publikováno v: Skeletal radiology [Skeletal Radiol] 2024 Sep; Vol. 53 (9), pp. 1815-1831. Date of Electronic Publication: 2024 Jul 15.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fat suppression at three-dimensional T1-weighted MR imaging of the hands: Dixon method versus CHESS technique

Autor: Kirchgesner, T., Perlepe, V., Michoux, N., Larbi, A., Vande Berg, B.

Publikováno v: In Diagnostic and Interventional Imaging January 2018 99(1):23-28